Evidence map›Paper›PMID 35456526›Full record

ArticlePharmaceutics2022

New Peptide Based Fluconazole Conjugates with Expanded Molecular Targets.

Wioletta Brankiewicz, Joanna Okońska, Katarzyna Serbakowska, Jan Lica, Marek Drab, Natalia Ptaszyńska, Anna Łęgowska, Krzysztof Rolka, Piotr Szweda

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Research advances in peptide‒drug conjugates.Acta pharmaceutica Sinica. B · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wioletta BrankiewiczDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland.ORCID 0000-0002-8314-0775
Joanna OkońskaDepartment of Molecular Biochemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdańsk, Poland.
Katarzyna SerbakowskaDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland.
Jan LicaDepartment of Molecular Biochemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdańsk, Poland.ORCID 0000-0001-6374-3635
Marek DrabUnit of Nanostructural Bio-Interactions, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigla-Street, 53-114 Wrocław, Poland.
Natalia PtaszyńskaDepartment of Molecular Biochemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdańsk, Poland.ORCID 0000-0001-7576-0248
Anna ŁęgowskaDepartment of Molecular Biochemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdańsk, Poland.ORCID 0000-0003-1665-3180
Krzysztof RolkaDepartment of Molecular Biochemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdańsk, Poland.ORCID 0000-0002-4537-700X
Piotr SzwedaDepartment of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland.ORCID 0000-0001-8291-5148
University of Gdańsk · PLGdańsk University of Technology · PLLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

National Science Centre (NCN, Poland) UMO-2016/21/B/ST5/00101.
6 · The paper itself

Abstract

Infections of

Indexed as

antimicrobial peptidesCandidacell penetrating peptidesfluconazolepeptide-drug conjugatesresistance

Identifiers

PMID35456526
PMCPMC9026428
OpenAlexW4220936036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.